Chemveda Life Sciences To Invest Rs 150 Cr For Expansion In Hyderabad

Chemveda Life Sciences has announced that it will invest Rs 150 crore for the expansion of its footprint in Hyderabad.

The announcement was made after Telangana's Industry Minister K.T. Rama Rao, who is on a visit to the United States, met the company heads in San Diego on Monday.

Chemveda Life Sciences is a Hyderabad and San Diego headquartered mid-sized contract research organisation which provides solutions to the pharmaceutical, biotechnology and agrochemical industries, along with the academia.

In the last five years, with two R&D sites, an area of over 65,000 sq ft and a manufacturing facility spread across eight acres, Chemveda Life Sciences has expanded from 45 employees in 2017 to over 450 employees now.

It will invest an additional Rs 150 crore to add a state-of-the-art R&D centre in Hyderabad, creating additional employment for 500 scientists.

It has already received a funding of Rs 90 crore and another Rs 60 crore funding has been committed. The company announced that it will add a GMP facility with a 200 KL capacity.

K.T Rama Rao said that he was delighted to see the industry benefiting from the active research ecosystem, progressive government policies, and abundant talent pool in Hyderabad.

"Hyderabad is one of the most preferred global destinations for pharma and biotech companies to seek contract research support. We feel privileged to be a part of one of the most cost-competitive and extensive ecosystems to run life sciences R&D," said Bheema Rao Paraselli, President and CEO, Chemveda.

--IANS

ms/arm

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor